权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Gli Control of PTH-rP and Osteolysis in Breast Cancer

Gli 控制乳腺癌中的 PTH-rP 和骨质溶解

基本信息

批准号：
7392366
负责人：
GREGORY R MUNDY
金额：
$ 17.14万
依托单位：
VANDERBILT UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-07-18 至 2010-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7392366
关键词：
26S proteasome 5&apos Flanking Region Adult Binding Biological Assay Bone Resorption Breast Breast Cancer Cell Breast Cancer Treatment Cell Line Cell membrane Cells Chondrocytes Conditioned Culture Media Cultured Cells Data Development Dominant-Negative Mutation Drosophila genus Electrophoretic Mobility Shift Assay Epiphysial cartilage Erinaceidae F Box Domain Family Family member Gene Expression Gene Targeting Genes Genetic Transcription Goals Heterozygote Homologous Gene Homologous Protein Human Hypercalcemia Hypercalcemia of Malignancy In Vitro Japan Knockout Mice Knowledge Laboratories Lead Length Life Lytic Metastatic Lesion MCF7 cell Malignant Neoplasms Malignant neoplasm of lung Mediating Mediator of activation protein Molecular Molecular Target Mus Mutate Northern Blotting Nucleic Acid Regulatory Sequences Nude Mice Oligonucleotides Osteoclasts Osteolysis Pathologic Pathway interactions Patients Pharmaceutical Preparations Phenotype Prevention Principal Investigator Process Production Prostate carcinoma Protein Family Protein Overexpression Proteins Regulation Regulatory Pathway Research Personnel Response Elements Role Route Series Signaling Molecule Signaling Protein Site Skeleton Small Interfering RNA Specificity System TNFSF11 gene Testing Transcription Coactivator Transfection Tumor Burden Ubiquitin Ubiquitination Work base beta-Transducin Repeat-Containing Proteins bone bone morphogenetic protein 2 cancer cell concept cytokine in vivo inhibitor/antagonist knock-down loss of function malignant breast neoplasm member multicatalytic endopeptidase complex mutant novel parathyroid hormone-related protein postnatal prenatal programs promoter research study smoothened signaling pathway transcription factor ubiquitin-protein ligase

项目摘要

DESCRIPTION (provided by applicant): Parathyroid hormone-related peptide (PTH-rP) is the causative factor not only in humoral hypercalcemia of malignancy (HHM), but also in the local osteolysis associated with metastatic breast cancer. The reasons for overexpression of PTH-rP by cancer cells in these situations are unknown. In breast cancer, there is almost universal expression of PTH-rP in bone metastatic sites. Pharmacologic inhibition of PTH-rP transcription in bone causes reduction in osteolysis and tumor burden in that site (Gallwitz et al., 2002). Understanding the mechanisms responsible for PTH-rP overexpression by cancer cells could thus lead to identification of molecular targets for drugs that could be effective in the prevention or treatment of breast cancer and other cancers that are associated with increased PTH-rP expression. We hypothesize that the Gli family of transcription factors, the hedgehog signaling molecules in vertebrate cells, are important heretofore uninvestigated regulators of PTH-rP expression in metastatic human breast cancer cells. We propose that Gli family members have distinct and separate functions with respect to regulating PTH-rP expression. Gli2 is a powerful transcriptional activator, and the truncated form of Gli3 (produced by the actions of the specific E3 ubiquitin ligase beta-TrCP and subsequent proteasomal processing) is a strong repressor of PTH-rP transcription. (Gli1 and Gli2 are not processed to truncated repressor forms, and full length Gli1 and Gli3 have no significant effects on PTH-rP transcription according to our Preliminary Data). Our preliminary data suggests that human breast cancer cells overexpress Gli2, and that transient transfection of these cells with Gli2 and truncated Gli3 regulate PTH-rP expression. Expression of endogenous Gli2 in breast cancer cells correlates with PTH-rP expression and capacity to cause hypercalcemia or osteolysis. Cancer cells stably transfected with Gli2 cause enhanced osteolysis in vivo. We plan to test our hypothesis by determining if Gli2 and truncated Gli3 enhance or reduce PTH-rP expression and osteolysis induced by human breast cancer cells in vivo, identify the molecular mechanisms whereby Gli2 enhances PTH-rP transcription, determine the effects of loss of function of Gli2 and the E3 ligase for Gli3, beta-TrCP, on PTH-rP expression and osteolysis, and the role of Gli2 and truncated Gli3 in other PTH-rP overexpressing cancer cells that cause HHM. We propose therefore that the Gli family of transcriptional regulators represents an important molecular pathway that regulates PTH-rP expression in breast cancer cells, and subsequent breast cancer-mediated osteolysis.

描述（由申请方提供）：甲状旁腺素相关肽（PTH-rP）不仅是恶性肿瘤体液性高钙血症（HHM）的致病因素，也是与转移性乳腺癌相关的局部骨质溶解的致病因素。在这些情况下，癌细胞过度表达PTH-rP的原因尚不清楚。在乳腺癌中，PTH-rP在骨转移部位几乎普遍表达。骨中PTH-rP转录的药理学抑制导致该部位的骨质溶解和肿瘤负荷减少（Gallwitz等人，2002年）。因此，了解负责癌细胞PTH-rP过表达的机制可能会导致识别药物的分子靶点，这些药物可能有效地预防或治疗乳腺癌和其他与PTH-rP表达增加相关的癌症。我们推测，Gli家族的转录因子，刺猬信号分子在脊椎动物细胞中，是重要的迄今未调查的调节PTH-rP在转移性人乳腺癌细胞中的表达。我们认为Gli家族成员在调节PTH-rP表达方面具有独特和独立的功能。 Gli 2是一种强大的转录激活因子，而截短形式的Gli 3（由特异性E3泛素连接酶β-TrCP和随后的蛋白酶体加工作用产生）是PTH-rP转录的强阻遏物。 (Gli1和Gli 2不被加工成截短的阻遏物形式，并且根据我们的初步数据，全长Gli 1和Gli 3对PTH-rP转录没有显著影响）。我们的初步数据表明，人乳腺癌细胞过度表达Gli 2，这些细胞与Gli 2和截短Gli 3调节PTH-rP表达的瞬时转染。乳腺癌细胞中内源性Gli 2的表达与PTH-rP表达和引起高钙血症或骨质溶解的能力相关。用Gli 2稳定转染的癌细胞在体内引起增强的骨质溶解。我们计划通过确定Gli 2和截短的Gli 3是否增强或减少人乳腺癌细胞体内诱导的PTH-rP表达和骨质溶解来验证我们的假设，确定Gli 2增强PTH-rP转录的分子机制，确定Gli 2和Gli 3的E3连接酶β-TrCP功能丧失对PTH-rP表达和骨质溶解的影响，以及Gli 2和截短的Gli 3在导致HHM的其他PTH-rP过表达癌细胞中的作用。因此，我们建议Gli家族的转录调节因子代表了一个重要的分子途径，调节PTH-rP在乳腺癌细胞中的表达，以及随后的乳腺癌介导的骨质溶解。